These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31994005)

  • 21. Screening models using multiple markers for early detection of late-onset preeclampsia in low-risk pregnancy.
    Park HJ; Kim SH; Jung YW; Shim SS; Kim JY; Cho YK; Farina A; Zanello M; Lee KJ; Cha DH
    BMC Pregnancy Childbirth; 2014 Jan; 14():35. PubMed ID: 24444293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Application of a Graphene Oxide-Based Surface Plasmon Resonance Biosensor to Measure First-Trimester Serum Pregnancy-Associated Plasma Protein-A/A2 Ratio to Predict Preeclampsia.
    Chen CY; Wang YH; Chen CP; Sun FJ; Chen YY; Huang YJ; Chiu NF
    Int J Nanomedicine; 2023; 18():7469-7481. PubMed ID: 38090367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. First-trimester serum analytes, biophysical tests and the association with pathological morphometry in the placenta of pregnancies with preeclampsia and fetal growth restriction.
    Odibo AO; Zhong Y; Longtine M; Tuuli M; Odibo L; Cahill AG; Macones GA; Nelson DM
    Placenta; 2011 Apr; 32(4):333-8. PubMed ID: 21324404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Impact of Aspirin on Ultrasound Markers of Uteroplacental Flow in Low-Risk Pregnancy: Secondary Analysis of a Multicenter RCT.
    Mulcahy C; Mone F; McParland P; Breathnach F; Cody F; Morrison JJ; Higgins J; Daly S; Dornan S; Cotter A; Dicker P; Tully E; Malone FD; McAuliffe FM
    Am J Perinatol; 2019 Jul; 36(8):855-863. PubMed ID: 30396226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The potential role of pregnancy-associated plasma protein-A2 in angiogenesis and development of preeclampsia.
    Chen X; Chen K; Feng Y; Ren C; Li W; Xiao J; Fan L; Beejadhursing R; Xi L; Chen S
    Hypertens Res; 2019 Jul; 42(7):970-980. PubMed ID: 30816319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
    Holme AM; Roland MC; Henriksen T; Michelsen TM
    Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening test for preeclampsia through assessment of uteroplacental blood flow and biochemical markers of oxidative stress and endothelial dysfunction.
    Parra M; Rodrigo R; Barja P; Bosco C; Fernández V; Muñoz H; Soto-Chacón E
    Am J Obstet Gynecol; 2005 Oct; 193(4):1486-91. PubMed ID: 16202744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor.
    Espinoza J; Romero R; Nien JK; Gomez R; Kusanovic JP; Gonçalves LF; Medina L; Edwin S; Hassan S; Carstens M; Gonzalez R
    Am J Obstet Gynecol; 2007 Apr; 196(4):326.e1-13. PubMed ID: 17403407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic carbon monoxide inhalation during pregnancy augments uterine artery blood flow and uteroplacental vascular growth in mice.
    Venditti CC; Casselman R; Murphy MS; Adamson SL; Sled JG; Smith GN
    Am J Physiol Regul Integr Comp Physiol; 2013 Oct; 305(8):R939-48. PubMed ID: 23986360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations in uteroplacental blood flow precede hypertension in preeclampsia at high altitude.
    Zamudio S; Palmer SK; Dahms TE; Berman JC; Young DA; Moore LG
    J Appl Physiol (1985); 1995 Jul; 79(1):15-22. PubMed ID: 7559213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maternal cardiac parameters can help in differentiating the clinical profile of preeclampsia and in predicting progression from mild to severe forms.
    Di Pasquo E; Ghi T; Dall'Asta A; Angeli L; Fieni S; Pedrazzi G; Frusca T
    Am J Obstet Gynecol; 2019 Dec; 221(6):633.e1-633.e9. PubMed ID: 31226294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Routine first-trimester combined screening for pre-eclampsia: pregnancy-associated plasma protein-A or placental growth factor?
    Noël L; Guy GP; Jones S; Forenc K; Buck E; Papageorghiou AT; Thilaganathan B
    Ultrasound Obstet Gynecol; 2021 Oct; 58(4):540-545. PubMed ID: 33998078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of pre-eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy-associated plasma protein-A, free beta-human chorionic gonadotropin, activin A and inhibin A at 22 + 0 to 24 + 6 weeks' gestation.
    Spencer K; Yu CK; Savvidou M; Papageorghiou AT; Nicolaides KH
    Ultrasound Obstet Gynecol; 2006 Jun; 27(6):658-63. PubMed ID: 16493628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum Inhibin-A and PAPP-A2 in the prediction of pre-eclampsia during the first and second trimesters in high-risk women.
    Keikkala E; Forstén J; Ritvos O; Stenman UH; Kajantie E; Hämäläinen E; Räikkönen K; Villa PM; Laivuori H
    Pregnancy Hypertens; 2021 Aug; 25():116-122. PubMed ID: 34116346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First-trimester screening for early and late preeclampsia using maternal characteristics, biomarkers, and estimated placental volume.
    Sonek J; Krantz D; Carmichael J; Downing C; Jessup K; Haidar Z; Ho S; Hallahan T; Kliman HJ; McKenna D
    Am J Obstet Gynecol; 2018 Jan; 218(1):126.e1-126.e13. PubMed ID: 29097177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased levels of pregnancy-associated plasma protein-A2 in the serum of pre-eclamptic patients.
    Nishizawa H; Pryor-Koishi K; Suzuki M; Kato T; Kogo H; Sekiya T; Kurahashi H; Udagawa Y
    Mol Hum Reprod; 2008 Oct; 14(10):595-602. PubMed ID: 18805800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maternal serum insulin-like growth factor-binding protein-3 (IGFBP-3) at 11-13 weeks in preeclampsia.
    Sifakis S; Akolekar R; Kappou D; Mantas N; Nicolaides KH
    J Hum Hypertens; 2012 Apr; 26(4):253-8. PubMed ID: 21368777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Placental size and the prediction of severe early-onset intrauterine growth restriction in women with low pregnancy-associated plasma protein-A.
    Proctor LK; Toal M; Keating S; Chitayat D; Okun N; Windrim RC; Smith GC; Kingdom JC
    Ultrasound Obstet Gynecol; 2009 Sep; 34(3):274-82. PubMed ID: 19672838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maternal serum pregnancy-associated plasma protein-A concentration at 11-14 weeks of gestation and preeclampsia risk of women with common congenital anatomic uterine abnormalities.
    Sotiriou S; Satra M; Samara A; Vamvakopoulou D; Simou A; Tzelepis K; Skentou H; Vamvakopoulos N; Garas A
    J Obstet Gynaecol; 2022 Aug; 42(6):1711-1714. PubMed ID: 35164639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased homodimerization and increased TIMP-1 complexation of uteroplacental and uterine arterial matrix metalloproteinase-9 during hypertension-in-pregnancy.
    Chen J; Ren Z; Zhu M; Khalil RA
    Biochem Pharmacol; 2017 Aug; 138():81-95. PubMed ID: 28506758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.